Thompson Kimberly M, Kalkowska Dominika A, Badizadegan Kamran
Kid Risk, Inc, Orlando, FL, USA.
Gates Open Res. 2022 Feb 3;6:5. doi: 10.12688/gatesopenres.13524.1. eCollection 2022.
: Investments made by countries and donors to support polio eradication and the Global Polio Eradication Initiative (GPEI) over the past 35 years provided financial support for significant health interventions beyond the prevention of polio. Prior economic analyses that sought to quantify the economic benefits of some interventions encountered insufficient data and evidence associated with non-polio-specific activities. The 2022-2026 GPEI Strategic Plan explicitly identified integration and gender equity as funded mandates that must move forward in parallel with polio eradication, but these goals remain vaguely defined from a health economic perspective. : To ensure unambiguous and full accounting for all financial investments in the GPEI, polio eradication, and other desirable objectives, we identify the health economic analysis methods and inputs needed to ensure transparent financial accountability and cost-effective use of funds. : Sufficient inputs and methods exist to characterize the health and economic benefits of polio-specific activities, but we identified the need for additional information and method development for some non-polio-specific and cost-sharing activities. Donors who seek to support non-polio-specific objectives as part of the GPEI may want to provide dedicated support financing for which it may be difficult to apply typical health economic criteria and to expect net health and/or net economic benefits. : Given the mixture of funding sources provided to the GPEI, which includes support by governments and private donors, we recommend that the GPEI separately account for financial needs that represent necessities for polio eradication from those used for other stated objectives. An added layer of specificity that identifies all funds according to each activity, the accountable party and/or parties, and the associated measurable health or other outcome(s), will enable improved health economic analyses and reporting to donors who seek to track returns on their investments.
在过去35年里，各国和捐助方为支持根除脊髓灰质炎及全球根除脊髓灰质炎行动（GPEI）所做的投资，为除预防脊髓灰质炎之外的重大卫生干预措施提供了资金支持。以往试图量化某些干预措施经济效益的经济分析，遇到了与非脊髓灰质炎特定活动相关的数据和证据不足的问题。2022 - 2026年GPEI战略计划明确将整合和性别平等确定为必须与根除脊髓灰质炎并行推进的受资助任务，但从卫生经济角度来看，这些目标的定义仍较为模糊。为确保对GPEI、根除脊髓灰质炎及其他预期目标的所有财政投资进行明确且全面的核算，我们确定了所需的卫生经济分析方法和投入，以确保资金的透明财务问责和成本效益使用。有足够的投入和方法来描述脊髓灰质炎特定活动的健康和经济效益，但我们发现对于一些非脊髓灰质炎特定活动和成本分摊活动，需要更多信息和方法开发。作为GPEI一部分寻求支持非脊髓灰质炎特定目标的捐助方，可能希望提供专门的支持资金，而对于这些资金可能难以应用典型的卫生经济标准，也难以期望获得净健康和/或净经济效益。鉴于提供给GPEI的资金来源多样，包括政府和私人捐助方的支持，我们建议GPEI将用于根除脊髓灰质炎的必要资金需求与用于其他既定目标的资金需求分开核算。增加一层根据每项活动、负责方和/或多方以及相关可衡量的健康或其他结果来识别所有资金的具体程度，将有助于改进卫生经济分析，并向寻求追踪投资回报的捐助方进行报告。
